United States (Remote, with up to 30% travel) Position Summary Natera is seeking a Vice President ... Cancer Detection and Signatera MRD), alongside corporate-level support for Women's Health and Organ ...
United States (Remote, with up to 30% travel) Position Summary Natera is seeking a Vice President ... Cancer Detection and Signatera MRD), alongside corporate-level support for Women's Health and Organ ...
Remote Cancer Registry information
See Oregon salary details
$12.20 - $15.46
2% of jobs
$15.46 - $18.72
9% of jobs
$21.91 is the 25th percentile. Wages below this are outliers.
$18.72 - $21.97
14% of jobs
$21.97 - $25.23
16% of jobs
The median wage is $28.31 / hr.
$25.23 - $28.49
9% of jobs
$28.49 - $31.75
15% of jobs
$34.49 is the 75th percentile. Wages above this are outliers.
$31.75 - $35
12% of jobs
$35 - $38.26
8% of jobs
$38.26 - $41.52
4% of jobs
$41.52 - $44.78
8% of jobs
$44.78 - $48.04
2% of jobs
$12
$30
$48
How much do remote cancer registry jobs pay per hour?
How hard is it to become a cancer registrar?
Are cancer registrars in demand?
How much money do cancer registrars make?
What is a Remote Cancer Registry professional?
Do cancer registrars work remotely?
What are some common challenges faced by professionals working in a remote cancer registry role?
What is the difference between Remote Cancer Registry vs Remote Oncology Data Coordinator?
| Aspect | Remote Cancer Registry | Remote Oncology Data Coordinator |
|---|---|---|
| Certifications | Certified Tumor Registrar (CTR) | CTR or similar certifications often preferred |
| Work Environment | Healthcare facilities, cancer centers, hospitals | Hospitals, clinics, healthcare organizations |
| Industry Usage | Primarily in cancer registries and epidemiology | In oncology departments managing patient data |
| Job Focus | Data collection, cancer case reporting, compliance | Data entry, record management, data quality assurance |
While both roles involve handling oncology data, the Remote Cancer Registry focuses on cancer case reporting and registry management, often requiring CTR certification. The Remote Oncology Data Coordinator handles broader patient data within oncology departments, emphasizing data accuracy and record keeping. Both roles are essential in oncology healthcare but differ in scope and specific responsibilities.
What are the key skills and qualifications needed to thrive as a Remote Cancer Registrar, and why are they important?
- Remote Clinical Data Abstractor
- Remote Nurse Abstractor
- Non Certified Oncology Data Specialist
- Remote Certified Billing Coding Specialist Cbcs
- Freelance Remote Cancer Registry Abstractor
- Remote Clinical Subject Matter Expert
- Remote Abstractor
- Remote Oncology Coding
- Oncology Abstractor
- Remote Radiation Oncology Consulting

Other
Re-posted 26 days ago
Natera rating
7.6
Based on 37 frontline employees who took The Breakroom Quiz
60th of 120 rated laboratories
Job description
Reports to: Chief Medical Officer, Corporate
Location: United States (Remote, with up to 30% travel)
Position Summary
Natera is seeking a Vice President of Clinical Development to deliver absolute ownership over the strategy, design, and execution of Natera-sponsored clinical studies. This corporate leader will institutionalize clinical trial architecture across the enterprise, distinct from therapeutic area strategy, with an immediate focus on defending and expanding our oncology footprint (including Early Cancer Detection and Signatera MRD), alongside corporate-level support for Women's Health and Organ Health.
Reporting directly to the Chief Medical Officer, you will be accountable for the operational health, scientific validity, and clinical utility data generated by Natera's multi-million dollar sponsored study portfolio. This is a high-autonomy role for a builder who can navigate rapid structural transitions-specifically our evolution from a Laboratory Developed Test (LDT) framework into highly regulated FDA In Vitro Diagnostic (IVD) and Companion Diagnostic (CDx) pharma partnerships.
Key Responsibilities
- Portfolio Architecture & Governance: Establish and enforce portfolio-level governance models to monitor study health, site enrollment, milestone delivery, sample flow, and data readiness. Make definitive, data-driven go/no-go decisions on trial modifications, accelerations, or terminations based on objective strategic value and execution feasibility.
- Clinical Utility Design: Lead cross-functional teams to design high-impact prospective, observational, and decision-impact trials. Translate clinical questions into protocols that explicitly isolate and prove clinical validity, analytical validity, and decision-impact endpoints to secure broad commercial payer coverage and medical guideline inclusion.
- Regulatory & CDx Alignment: Partner with Regulatory affairs to build clinical evidence strategies that support FDA pre-market approval (PMA), 510(k), and De Novo pathways. Lead intended-use claim strategy and protocols that support companion diagnostic (CDx) co-development with biopharma partners.
- Operational Study Health: Direct internal Clinical Operations and external CROs to eliminate bottlenecks in site activation, sample transit degradation, and query resolution. Implement fast, corrective action plans for under-performing sites or delayed protocols.
- Scientific Footprint & Influence: Maintain and build a direct, peer-to-peer scientific relationship with leading academic investigators, cooperative groups, and guideline panel members. Personally author and contribute to landmark peer-reviewed publications and abstract presentations at major oncology and diagnostic symposia.
Qualifications
- MD, MD/PhD, or PhD with equivalent oncology pivotal or registrational trial leadership experience.
- 18+ years of experience in clinical development, clinical research, or clinical evidence generation, including at least 10 years personally directing oncology clinical trials.
- Diagnostics-native fluency: deep, unassisted comfort discussing cell-free DNA (cfDNA), ctDNA dynamics, minimal residual disease (MRD), analytical vs. clinical validity, and decision-impact metrics.
- Demonstrated experience operating cross-functionally within a highly matrixed environment with direct authority over clinical portfolios.
- Proven track record of designing evidence strategies that directly influenced regulatory submissions, multi-site registries, or national coverage determinations (LCDs/payors).
- High tolerance for ambiguity and an active bias for action; comfortable making critical portfolio trade-offs with incomplete information.